{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T13:15:56Z","timestamp":1758201356589,"version":"3.44.0"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-112218"],"award-info":[{"award-number":["TSGH-E-112218"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-113238"],"award-info":[{"award-number":["TSGH-E-113238"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-016-033"],"award-info":[{"award-number":["NSTC 112-2314-B-016-033"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-016-052"],"award-info":[{"award-number":["NSTC 113-2314-B-016-052"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medical Case Reports"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Systemic lupus erythematosus is a chronic autoimmune disease often presenting with cutaneous symptoms such as malar rash. While hydroxychloroquine is standard therapy, some cases remain treatment-resistant. Molecular hydrogen possesses anti-inflammatory and immunomodulatory effects in autoimmune disorders. This case report examines the use of molecular hydrogen as adjunctive therapy in a 27-year-old woman with systemic lupus erythematosus and refractory malar rash. Despite hydroxychloroquine treatment, her rash persisted and significantly impacted the quality of life. After initiating oral molecular hydrogen therapy, the patient showed sustained clinical improvement, including reduced malar rash, decreased fatigue, and enhanced well-being over several months. These outcomes were accompanied by notable immunological changes: increased killer cell lectin-like receptor G1 positive effector T cells, decreased plasmablast activity, stabilization of B cell exhaustion markers, and reductions in and a decline in antinuclear antibody and anti-double-stranded DNA antibody levels. This case suggests that molecular hydrogen may be a safe and promising adjunctive treatment for cutaneous manifestations and systemic immune modulation in systemic lupus erythematosus.<\/jats:p>","DOI":"10.1177\/2050313x251372755","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T11:27:27Z","timestamp":1757935647000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive molecular hydrogen therapy for refractory malar rash in systemic lupus erythematosus: A case report with immunological insights"],"prefix":"10.1177","volume":"13","author":[{"given":"Nai-Sung","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Wei","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan, Republic of China"},{"name":"Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark"},{"name":"The Finsen Laboratory, Faculty of Health and Medical Sciences, Rigshospitalet\/National University Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jung","family":"Ho","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, Republic of China"},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Yih","family":"Wang","sequence":"additional","affiliation":[{"name":"Rheumatology\/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-8309","authenticated-orcid":false,"given":"Feng-Cheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Rheumatology\/Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.11.001"},{"key":"e_1_3_3_3_2","first-page":"439","article-title":"Systemic lupus erythematosus (SLE): trials and issues","volume":"4","author":"Moldovan I","year":"2004","unstructured":"Moldovan I, Ginzler EM. Systemic lupus erythematosus (SLE): trials and issues. Discov Med 2004; 4: 439\u2013443.","journal-title":"Discov Med"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340802"},{"key":"e_1_3_3_5_2","article-title":"Cutaneous manifestations of systemic lupus erythematosus and their correlation with cardiac involvement","volume":"16","author":"Zeb R","year":"2024","unstructured":"Zeb R, Chinome DVC, Chacon M, et al. Cutaneous manifestations of systemic lupus erythematosus and their correlation with cardiac involvement. Cureus 2024; 16: e76478.","journal-title":"Cureus"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.11.008"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.10.003"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4528547"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22780"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13924"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.05.024"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aimed.2023.10.003"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13799"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1577"},{"key":"e_1_3_3_16_2","first-page":"4472","article-title":"Molecular hydrogen decelerates rheumatoid arthritis progression through inhibition of oxidative stress","volume":"8","author":"Meng J","year":"2016","unstructured":"Meng J, Yu P, Jiang H, et al. Molecular hydrogen decelerates rheumatoid arthritis progression through inhibition of oxidative stress. Am J Transl Res 2016; 8: 4472\u20134477.","journal-title":"Am J Transl Res"},{"key":"e_1_3_3_17_2","article-title":"Tumor-associated KLRG1+ Tregs drive a dominant immunosuppressive program in non-small cell lung cancer","volume":"212","author":"Oluwatola O","year":"2024","unstructured":"Oluwatola O, Oseni S, Bag A, et al. Tumor-associated KLRG1+ Tregs drive a dominant immunosuppressive program in non-small cell lung cancer. J Immunol 2024; 212(suppl 1): 0448_4095\u20130448_4095.","journal-title":"J Immunol"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231160979"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17959.1"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2017.9.20807"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13862"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13926"}],"container-title":["SAGE Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251372755","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X251372755","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251372755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T07:24:48Z","timestamp":1758180288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X251372755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"alternative-id":["10.1177\/2050313X251372755"],"URL":"https:\/\/doi.org\/10.1177\/2050313x251372755","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"type":"print","value":"2050-313X"},{"type":"electronic","value":"2050-313X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"2050313X251372755"}}